Development of clinical pharmacy in Belgian hospitals through pilot projects funded by the government. Issue 2 (4th March 2019)

• Record Type: Journal Article
• Authors: Somers, A.; Spinewine, A.; Spriet, I.; Steurbaut, S.; Tulkens, P.; Hecq, J. D.; Willems, L.; Robays, H.; Dhoore, M.; Yaras, H.; Vanden Bremt, I.; Haelterman, M.
• Is Part Of: Acta clinica belgica. Volume 74:Issue 2(2019)
• Page Start: 75
• Page End: 81
• Publication Date: 2019-03-04
• Subjects: Clinical pharmacy -- patient safety -- hospital pharmacist -- national pilot project -- indicators; Clinical medicine -- Periodicals; Diagnosis, Laboratory -- Periodicals; 616.005
• DOI: 10.1080/17843286.2018.1462877
• Languages: English
• ISSNs: 1784-3286

Abstract

Abstract: Objectives The goal is to develop clinical pharmacy in the Belgian hospitals to improve drug efficacy and to reduce drug-related problems. Methods From 2007 to 2014, financial support was provided by the Belgian federal government for the development of clinical pharmacy in Belgian hospitals. This project was guided by a national Advisory Working Group. Each funded hospital was obliged to describe yearly its clinical pharmacy activities. Results In 2007, 20 pharmacists were funded in 28 pilot hospitals; this number was doubled in 2009 to 40 pharmacists over 54 institutions, representing more than half of all acute Belgian hospitals. Most projects (72%) considered patient-related activities, whereas some projects (28%) had a hospital-wide approach. The projects targeted patients at admission (30%), during hospital stay (52%) or at discharge (18%). During hospital stay, actions were mainly focused on geriatric patients (20%), surgical patients (15%), and oncology patients (9%). Experiences, methods, and tools were shared during meetings and workshops. Structure, process, and outcome indicators were reported and strengths, weaknesses, opportunities, and threats were described. The yearly reports revealed that the hospital board was engaged in the project in 87% of the cases, and developed a vision on clinical pharmacy in 75% of the hospitals. In 2014, the pilot phase was replaced by structural financing for clinical pharmacy in all acute Belgian hospitals. Conclusion The pilot projects in clinical pharmacy funded by the federal government provided a unique opportunity to launch clinical pharmacy activities on a broad scale in Belgium. The results of the pilot projects showed clear implementation through case reports, time registrations, and indicators. Tools for clinical pharmacy activities were developed to overcome identified barriers. The engagement of hospital boards and the results of clinical pharmacy activities persuaded the government to start structural financing of clinical pharmacy.